Related Experiment Video
Updated: Jan 21, 2026

Isolation of Physiologically Active Thylakoids and Their Use in Energy-Dependent Protein Transport Assays
Published on: September 28, 2018
Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1
Mingqing Chen1, Claudia Neul2,3, Elke Schaeffeler2,3,4
1Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
Abstract:
Systemic therapy of advanced hepatocellular carcinoma (HCC) with the small-molecule multikinase inhibitor sorafenib is associated with large interindividual pharmacokinetic variability and unpredictable side effects potentially requiring dose reduction or treatment termination. Organic cation transporter (OCT1; gene SLC22A1) has been proposed as a clinical biomarker of HCC response. Because proof is lacking that OCT1 transports sorafenib, we used a combinatorial approach to define how OCT1 contributes to sorafenib transport. Overexpression of functional OCT1 protein in Xenopus laevis oocytes and mammalian cell lines did not facilitate sorafenib transport. Otherwise, sorafenib considerably accumulated in liver cancer cell lines despite negligible OCT1 mRNA and protein levels. Sorafenib pharmacokinetics was independent of OCT1 genotype in mice. Finally, SLC22A1 mRNA expression was significantly reduced by DNA methylation in The Cancer Genome Atlas HCC cohort. These results clearly demonstrate OCT1-independent cellular sorafenib uptake indicating that OCT1 is apparently not a valid biomarker of sorafenib response in HCC.
Insights
Organic cation transporter 1 (OCT1) does not transport sorafenib, a drug used for advanced hepatocellular carcinoma (HCC). This study indicates OCT1 is not a valid biomarker for predicting sorafenib response in HCC patients.
Area of Science:
- Pharmacology
- Oncology
- Molecular Biology
Background:
- Systemic therapy for advanced hepatocellular carcinoma (HCC) using sorafenib exhibits significant interindividual pharmacokinetic variability and unpredictable side effects.
- Organic cation transporter 1 (OCT1), encoded by the SLC22A1 gene, has been suggested as a potential clinical biomarker for predicting HCC treatment response.
Purpose of the Study:
- To investigate the role of OCT1 in the cellular uptake and transport of sorafenib.
- To determine if OCT1 functions as a transporter for sorafenib and assess its validity as a biomarker for sorafenib response in HCC.
Main Methods:
- Utilized Xenopus laevis oocytes and mammalian cell lines overexpressing functional OCT1 protein to assess sorafenib transport.
- Analyzed sorafenib accumulation in liver cancer cell lines with varying OCT1 expression levels.
- Examined sorafenib pharmacokinetics in mice with different OCT1 genotypes.
- Investigated SLC22A1 mRNA expression and its correlation with DNA methylation in The Cancer Genome Atlas (TCGA) HCC cohort.
Main Results:
- Overexpression of OCT1 in oocytes and cell lines did not facilitate sorafenib transport.
- Sorafenib accumulated in liver cancer cell lines irrespective of OCT1 mRNA and protein levels.
- Sorafenib pharmacokinetics in mice were independent of OCT1 genotype.
- SLC22A1 mRNA expression was significantly reduced by DNA methylation in HCC samples from the TCGA.
Conclusions:
- Cellular uptake of sorafenib is independent of OCT1.
- OCT1 is not a valid biomarker for predicting sorafenib response or guiding treatment decisions in advanced HCC.
More Related Videos
09:02Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers
Published on: August 10, 2020
12:48Measuring Cation Transport by Na,K- and H,K-ATPase in Xenopus Oocytes by Atomic Absorption Spectrophotometry: An Alternative to Radioisotope Assays
Published on: February 19, 2013
Related Concept Videos
Secondary Active Transport
Secondary Active Transport
Primary Active Transport
Primary Active Transport
Active Transport
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Facilitated Transport